The effect of oral diabetes medications on glycated haemoglobin (HbA1c) in Asians in primary care: a retrospective cohort real-world data study

BACKGROUND: Clinical trials have demonstrated that initiating oral anti-diabetic drugs (OADs) significantly reduce glycated hemoglobin (HbA1c) levels. However, variability in lifestyle modifications and OAD adherence impact on their actual effect on glycemic control. Furthermore, evidence on dose ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Hao Sen Andrew, Gao, Qiao, Tan, Wei Ying, Lee, Mong Li, Hsu, Wynne, Tan, Ngiap Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790837/
https://www.ncbi.nlm.nih.gov/pubmed/35078484
http://dx.doi.org/10.1186/s12916-021-02221-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790837/
https://www.ncbi.nlm.nih.gov/pubmed/35078484
http://dx.doi.org/10.1186/s12916-021-02221-z

Ejemplares similares